1-2 of 2
Blanca Xicoy
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

AML typical mutations (CEBPA, FLT3, and NPM1) identify a high-risk CMML independent of CPSS-Mol classification

Sandra Castaño-Díez, Mònica López-Guerra, Inés Zugasti, Xavier Calvo, Felicitas Isabel Schulz, Alejandro Avendaño, Elvira Mora, Jose Francisco Falantes-González, Gemma Azaceta, Mariam Ibañez, Tzu-Hua Chen-Liang, Cristina Notario Mc Donnell, Neus Amer-Salas, Laura Palomo, Helena Pomares, Jordi Vila, Teresa Bernal del Castillo, Carlos Jiménez-Vicente, Daniel Esteban, Francesca Guijarro, José Ramón Álamo Moreno, Albert Cortés-Bullich, Víctor Torrecillas-Mayayo, Ana Triguero, Lucía Mont-de Torres, Ester Carcelero, Aina Cardús, Ulrich Germing, Beate Betz, Maria Rozman, Leonor Arenillas, Lurdes Zamora, María Díez-Campelo, Blanca Xicoy, Jordi Esteve, Marina Díaz-Beyá
Journal: Blood Advances
Blood Adv bloodadvances.2024013648.
https://doi.org/10.1182/bloodadvances.2024013648
Published: 2024
Includes: Supplemental data
Journal Articles

Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials

Clinical Trials & Observations
Srdan Verstovsek, Ruben Mesa, Vikas Gupta, David Lavie, Viviane Dubruille, Nathalie Cambier, Uwe Platzbecker, Marek Hus, Blanca Xicoy, Stephen T. Oh, Jean-Jacques Kiladjian, Alessandro M. Vannucchi, Aaron Gerds, Miklos Egyed, Jiří Mayer, Tomasz Sacha, Jun Kawashima, Marc Morris, Mei Huang, Claire Harrison
Journal: Blood Advances
Blood Adv (2023) 7 (14): 3582–3591.
https://doi.org/10.1182/bloodadvances.2022009311
Published: 2023
Includes: Supplemental data